The outlook of companies tied to flagship drugs like Viagra presents a challenging investment scenario . While the initial rise of copyright, fueled by Viagra's extraordinary popularity, generated substantial profits , the expiry in key territories has introduced considerable volatility. Investors are now grappling with the consequences of rival me